Frequently Asked Questions
The market is segmented based on , By Therapy Type (Enzyme Replacement Therapy, Substrate Reduction Therapy, Gene Therapy, Drug Therapy, Others), Application (Lysosomal Storage Diseases, Diabetes, Obesity, Hypercholesterolemia, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
.
The Global Metabolic Disorders Therapeutics Market size was valued at USD 62.00 USD Billion in 2021.
The Global Metabolic Disorders Therapeutics Market is projected to grow at a CAGR of 7.5% during the forecast period of 2022 to 2029.
The major players operating in the market include Atkins Global, Herbalife International of America , Nutrisystem , Abbott, Kellogg Co., Mega Laboratories , Johnson & Johnson Private Limited, Medtronic, Apollo Endosurgery , GSK plc, Olympus Corporation, WW International , Jenny Craig, Gold’s Gym, DSM, Brunswick, Amer Sports, Johnson Health Tech, Technogym SpA, Shaklee Corporation, Nature's Sunshine Products , Novo Nordisk A/S.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
